Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sizhou Feng

Showing results (151-160 of 219) with videos related to

Pageof 22
Sort By:
Blood Science (Baltimore, Md.)|December 15, 2022
Risk factors for CMV infection within 100 days posttransplantation in patients with acute leukemiaJuan Chen, Aiming Pang, Yuanqi Zhao, et al.
Bone Marrow Transplantation|May 9, 2025
Divergent prognostic factors in high-risk vs. standard-risk patients aged 50-65 years after allo-HCT for AML/MDS: a single-center retrospective analysisWenwen Guo, Haixiao Zhang, Hongye Gao, et al.
Frontiers in Immunology|July 21, 2025
Impact of pre-transplant body mass index on outcomes in AML patients aged ≥ 50 years after allogeneic hematopoietic cell transplantationWenwen Guo, Haixiao Zhang, Hongye Gao, et al.
Annals of Hematology|December 13, 2025
Targeting relapsed/refractory and MRD + Ph + ALL: olverembatinib-venetoclax bridging enhances allo-HSCT outcome​Xiaoyu Zhang, Yanhong Zhao, Weihua Zhai, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 12, 2022
Efficacy of Recombinant Human Thrombopoietin for the Treatment of Secondary Failure of Platelet Recovery After Allogeneic HSCTYigeng Cao, Mingyang Wang, Biao Shen, et al.
British Journal of Haematology|March 30, 2023
Haematopoietic stem cell transplantation for hepatitis-associated aplastic anaemia and non-hepatitis-associated aplastic anaemia: A propensity score-matched analysisJia Li, Yan Wang, Yuanfeng Zhang, et al.
Open Forum Infectious Diseases|September 29, 2025
Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis: Results from the Double-blind, Randomized, Phase 3 ReSTORE Trial Including the China Extension StudyGeorge R Thompson, Haihui Huang, Sizhou Feng, et al.
Ebiomedicine|February 20, 2026
Platelets as immune sensors: monitoring immune dynamics and diagnosing disease states across multiple disordersLin Zheng, Dan Feng, Yuting Wu, et al.
Frontiers in Immunology|February 23, 2026
Impact of prior solid tumor on outcomes of hematopoietic stem cell transplantation for hematologic malignancies: a propensity score-matched studyJieya Luo, Mingyang Wang, Yunxia Zhou, et al.
British Journal of Haematology|June 2, 2026
Optimizing treatment selection and timing of allogeneic haematopoietic stem cell transplantation in acute myeloid leukaemia with concurrent feline McDonough sarcoma (FMS)-like tyrosine kinase 3 internal tandem duplication, nucleophosmin 1 and deoxyribonucleic acid (DNA) methyltransferase 3 alpha mutationsRuixin Li, Yiyi Yao, Donglin Yang, et al.
Pageof 22

Showing results (151-160 of 219) with videos related to

Sort By:
Pageof 22
Blood Science (Baltimore, Md.)|December 15, 2022
Risk factors for CMV infection within 100 days posttransplantation in patients with acute leukemiaJuan Chen, Aiming Pang, Yuanqi Zhao, et al.
Bone Marrow Transplantation|May 9, 2025
Divergent prognostic factors in high-risk vs. standard-risk patients aged 50-65 years after allo-HCT for AML/MDS: a single-center retrospective analysisWenwen Guo, Haixiao Zhang, Hongye Gao, et al.
Frontiers in Immunology|July 21, 2025
Impact of pre-transplant body mass index on outcomes in AML patients aged ≥ 50 years after allogeneic hematopoietic cell transplantationWenwen Guo, Haixiao Zhang, Hongye Gao, et al.
Annals of Hematology|December 13, 2025
Targeting relapsed/refractory and MRD + Ph + ALL: olverembatinib-venetoclax bridging enhances allo-HSCT outcome​Xiaoyu Zhang, Yanhong Zhao, Weihua Zhai, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 12, 2022
Efficacy of Recombinant Human Thrombopoietin for the Treatment of Secondary Failure of Platelet Recovery After Allogeneic HSCTYigeng Cao, Mingyang Wang, Biao Shen, et al.
British Journal of Haematology|March 30, 2023
Haematopoietic stem cell transplantation for hepatitis-associated aplastic anaemia and non-hepatitis-associated aplastic anaemia: A propensity score-matched analysisJia Li, Yan Wang, Yuanfeng Zhang, et al.
Open Forum Infectious Diseases|September 29, 2025
Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis: Results from the Double-blind, Randomized, Phase 3 ReSTORE Trial Including the China Extension StudyGeorge R Thompson, Haihui Huang, Sizhou Feng, et al.
Ebiomedicine|February 20, 2026
Platelets as immune sensors: monitoring immune dynamics and diagnosing disease states across multiple disordersLin Zheng, Dan Feng, Yuting Wu, et al.
Frontiers in Immunology|February 23, 2026
Impact of prior solid tumor on outcomes of hematopoietic stem cell transplantation for hematologic malignancies: a propensity score-matched studyJieya Luo, Mingyang Wang, Yunxia Zhou, et al.
British Journal of Haematology|June 2, 2026
Optimizing treatment selection and timing of allogeneic haematopoietic stem cell transplantation in acute myeloid leukaemia with concurrent feline McDonough sarcoma (FMS)-like tyrosine kinase 3 internal tandem duplication, nucleophosmin 1 and deoxyribonucleic acid (DNA) methyltransferase 3 alpha mutationsRuixin Li, Yiyi Yao, Donglin Yang, et al.
Pageof 22